Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.4 (
chondroitinase
)
2,039
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thrombospondin-1
(
TSP1
) has potent biological effects on vasculature smooth muscle cells (SMCs) and endothelial cells. The regulation of extracellular accumulation of
TSP1
is mediated by a previously obscure process of endocytosis which leads to its lysosomal degradation. Since members of the low density lipoprotein receptor (LDLR) family have been found to mediate endocytosis which leads to degradation of a diverse array of ligands, we evaluated their possible role in the uptake and degradation of
TSP1
by vascular SMCs, endothelial-cells and fibroblasts. 125I-
TSP1
was found to be internalized and degraded lysosomally by all these cell types. Both the internalization and degradation of 125I-
TSP1
could be inhibited by a specific antagonist of the LDLR family, the 39-kD receptor-associated protein (RAP). Antibodies to the LDLR-related protein (LRP) completely blocked the uptake and degradation of 125I-
TSP1
in SMCs and fibroblasts but not endothelial cells. Solid-phase binding assays confirmed that LRP bound to
TSP1
and that the interaction was of high affinity (Kd = 5 nM). Neither RAP nor LRP antibodies inhibited the binding of 125I-
TSP1
to surfaces of SMCs. However, cell surface binding, as well as, endocytosis and degradation could be blocked by heparin or by pre-treatment of the cells with either heparitinase,
chondroitinase
or beta-D-xyloside. The data indicates that cell surface proteoglycans are involved in the LRP-mediated clearance of
TSP1
. A model for the clearance of
TSP1
by these cells is that
TSP1
bound to proteoglycans is presented to LRP for endocytosis. In endothelial cells, however, the internalization of
TSP1
was not mediated by LRP but since RAP inhibited
TSP1
uptake and degradation, we postulate that another member of the LDLR family is likely to be involved.
...
PMID:Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. 777 83